Page last updated: 2024-08-21

vancomycin and simvastatin

vancomycin has been researched along with simvastatin in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	7 (70.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Adah, F; Benghuzzi, H; England, B; Russell, G; Tucci, M	1
Cogo-Müller, K; Cuzzullin, MC; de Andrade, ED; Franco, GC; Graziano, TS; Groppo, FC; Schwartz-Filho, HO	1
Baulard, A; Daffé, M; Denis, O; Fontaine, V; Frita, R; Laval, F; Lefèvre, P; Rens, C; Wattiez, R	1
Cho, JY; Jang, IJ; Ji, SC; Kim, AH; Lee, S; Sunwoo, J; Yu, KS	1

Reviews

1 review(s) available for vancomycin and simvastatin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for vancomycin and simvastatin

Article	Year
Impact of Vancomycin-Induced Changes in the Intestinal Microbiota on the Pharmacokinetics of Simvastatin. Clinical and translational science, 2020, Volume: 13, Issue:4 Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacteroidetes; Cross-Over Studies; Drug Interactions; Feces; Gastrointestinal Microbiome; Glucuronic Acid; Healthy Volunteers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolomics; Middle Aged; Proteobacteria; Simvastatin; Vancomycin; Young Adult	2020

Article

Year

Impact of Vancomycin-Induced Changes in the Intestinal Microbiota on the Pharmacokinetics of Simvastatin.

Clinical and translational science, 2020, Volume: 13, Issue:4

Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacteroidetes; Cross-Over Studies; Drug Interactions; Feces; Gastrointestinal Microbiome; Glucuronic Acid; Healthy Volunteers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolomics; Middle Aged; Proteobacteria; Simvastatin; Vancomycin; Young Adult

2020

Other Studies

8 other study(ies) available for vancomycin and simvastatin

Article	Year
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Cholesterol production inhibitor (statin) increased bone healing in surgically created femoral defect in an animal model. Biomedical sciences instrumentation, 2007, Volume: 43 Topics: Animals; Anticholesteremic Agents; Disease Models, Animal; Drug Combinations; Femoral Fractures; Femur; Fracture Healing; Male; Osteogenesis; Rats; Rats, Sprague-Dawley; Simvastatin; Treatment Outcome; Vancomycin	2007
Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm. PloS one, 2015, Volume: 10, Issue:5 Topics: Anti-Bacterial Agents; Anticholesteremic Agents; Atorvastatin; Bacterial Adhesion; Biofilms; Drug Repositioning; Enterococcus faecalis; Escherichia coli; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Pravastatin; Pseudomonas aeruginosa; Simvastatin; Vancomycin	2015
Effects of Lipid-Lowering Drugs on Vancomycin Susceptibility of Mycobacteria. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10 Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Synergism; Fenofibrate; Hypolipidemic Agents; Lactones; Membrane Lipids; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Orlistat; Simvastatin; Vancomycin	2016